Omri Amirav-Drory, PhD
General Partner, NFX
Genome Compiler raised $6 million before its acquisition by Twist Bioscience in 2016. Its founding CEO, Omri Amirav-Drory, now leads NFX Bio. His experience spans genetic-engineering software, corporate development at Twist and investing in companies including Mammoth Biosciences and Immunai.
Sources
Brett Horton
Chief Investment Officer, Paris-Roubaix Group
Brett is Chief Investment Officer of Paris-Roubaix Group, a San Francisco single-family office. His investment experience spans venture capital, private equity, real assets, alternatives and direct investments, bringing an allocator’s perspective to company building and private markets.
Sources
Arnaud Auger
Director & Deputy Head of C.Lab, Cathay Innovation
Cathay Innovation announced its $1 billion Fund III in May 2025. Arnaud serves as Director and Deputy Head of C.Lab, its strategic advisory arm. Previously Deputy Head of BNP Paribas’ San Francisco Innovation Lab, he connects corporations and startups across financial services, health and retail.
Photo: Frederic Neema / Octamedia Productions
Sources
Rio Hodges
Associate Partner, Antler US
Rio is an Associate Partner at Antler US. Previously a Senior Strategist at frog, he worked on growth strategy and innovation, turning ideas into commercially viable products and services. His background also includes growth equity and early-stage venture investing.
Sources
Ryan Green
Principal, Antler — at the July 2026 event
Ryan’s work has focused on pre-seed investing and founder recruitment for Antler’s San Francisco residency. His background includes deep-tech and AI investing, product, deployment and go-to-market work. He began his career in industrial cybersecurity at Deloitte and studied Computer Engineering at Notre Dame.
Sources